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Protective effect of glycyrrhizin, 
a direct HMGB1 inhibitor, 
on post‑contrast acute kidney 
injury
Hyewon Oh1, Arom Choi2, Nieun Seo1, Joon Seok Lim1, Je Sung You2,3* & 
Yong Eun Chung1,3*
Post contrast‑acute kidney injury (PC‑AKI) is defined as the deterioration of renal function after 
administration of iodinated contrast media. HMGB1 is known to play an important role in the 
development of acute kidney injury. The purpose of this study was to investigate the association 
between HMGB1 and PC‑AKI and the protective effect of glycyrrhizin, a direct inhibitor of HMGB1, 
in rats. Rats were divided into three groups: control, PC‑AKI and PC‑AKI with glycyrrhizin. Oxidative 
stress was measured with MDA levels and  H2DCFDA fluorescence intensity. The mRNA expressions 
of pro‑inflammatory cytokines (IL‑1α, IL‑1β, IL‑6 and TNF‑α) and kidney injury markers (KIM‑1, 
NGAL and IL‑18) were assessed using RT‑PCR and ELISA in kidney tissue. In addition, the serum 
and intracellular protein levels of HMGB1were analyzed with the enzyme‑linked immunosorbent 
assay (ELISA) and western blotting. Histologic changes were assessed with H&E staining using the 
transmission electron microscope (TEM). Moreover, serum creatinine (SCr), blood urea nitrogen (BUN) 
and lactate dehydrogenase (LDH) levels were assessed. Oxidative stress, pro‑inflammatory cytokines, 
kidney injury markers and LDH were significantly higher in PC‑AKI compared to the controls, but 
were lower in PC‑AKI with glycyrrhizin. Intracellular and serum HMGB1 levels significantly increased 
after contrast media exposure, whereas they markedly decreased after glycyrrhizin pretreatment. 
SCr and BUN also decreased in PC‑AKI with glycyrrhizin compared to PC‑AKI. In PC‑AKI, we could 
frequently observe tubular dilatation with H&E staining and cytoplasmic vacuoles on TEM, whereas 
these findings were attenuated in PC‑AKI with glycyrrhizin. Our findings indicate that HMGB1 plays an 
important role in the development of PC‑AKI and that glycyrrhizin has a protective effect against renal 
injury and dysfunction by inhibiting HMGB1 and reducing oxidative stress.
Post-contrast acute kidney injury (PC-AKI) occurs in approximately 5–6% of patients after administration of 
intravenous contrast media and this incidence steeply increases in patients with impaired renal  function1. PC-
AKI is the third most common cause of acute renal failure in hospitalized  patients2,3 and can cause long-term 
adverse effects including loss of kidney function and increased morbidity and  mortality4. Although the pathogen-
esis of PC-AKI is not yet fully elucidated, suggested causes of PC-AKI are the direct toxicity of contrast media, 
contrast media-driven reactive oxygen species and/or renal hypoxia due to vasoconstriction or high viscosity 
of the contrast media  itself2,3.
The high-mobility group box 1 (HMGB1) exists in the nuclei of mammalian cells and is a novel member of the 
damage-associated molecular pattern (DAMP) family. HMGB1 can be actively released from the nucleus into the 
cytoplasm and extracellular space in response to sterile inflammation and infection when cell membrane recep-
tors interact with microbe-associated molecular patterns, pathogen-associated molecular patterns and inflam-
matory mediators such as tumor necrosis factor (TNF-α), IL-1 and interferon-γ. HMGB1 can also be passively 
released from necrotic or apoptotic  cells5,6. After excretion from the cell, HMGB1 acts as a pro-inflammatory 
mediator when it binds to cell surface receptors including advanced glycation end products (RAGE) or toll-like 
receptors (TLR) and stimulates immunocompetent cells to produce pro-inflammatory cytokines such as TNF-α, 
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IL-1, IL-6 and IL-8, resulting in symptoms such as fever, anorexia and other inflammatory  responses5,6. HMGB1 
also plays an important role in the pathogenesis of various diseases including sepsis, gastrointestinal inflam-
mation, respiratory disorders, autoimmune diseases, hemorrhagic shock, cerebral ischemia and myocardial 
 infarction6. HMGB1 is also involved in renal disease including acute kidney injury because HMGB1 can promote 
kidney injury through the TLR4  pathway7,8.
Glycyrrhizin is derived from licorice root extract and binds directly to the high-mobility group 1 (HMG1) box 
in HMGB1, consequently inhibiting the chemoattractant and mitogenic activity of  HMGB19–11. In AKI caused 
by ischemia–reperfusion injury, glycyrrhizin is thought to attenuate renal injury through this  inhibition12. As 
PC-AKI is classified as acute kidney injury, HMGB1 might be a factor in the development of PC-AKI. However, 
to our knowledge, no studies have explored the role of HMGB1 and the protective effect of glycyrrhizin against 
PC-AKI. So, the purpose of this study was to investigate the association between HMGB1 and PC-AKI and the 
protective effect of glycyrrhizin.
Results
Glycyrrhizin‑mitigated oxidative stress in PC‑AKI. We confirmed the effect of glycyrrhizin on reac-
tive oxygen species (ROS) in the PC-AKI group. The MDA levels were higher in the PC-AKI group compared 
to the controls (P < 0.001), whereas MDA levels were lower in the PC-AKI with glycyrrhizin group compared 
to the PC-AKI group (P < 0.001) (Fig. 1A). In addition, in  H2DCFDA staining, the fluorescence intensity of the 
PC-AKI group was markedly higher than the controls, whereas it was lower after glycyrrhizin pretreatment 
(Fig. 1B).
Effect of glycyrrhizin on the protein expression of HMGB1 in PC‑AKI. We evaluated whether gly-
cyrrhizin could inhibit the protein expression of HMGB1. The protein expression of intracellular (P < 0.001), 
cytoplasmic (P = 0.010) HMGB1 increased in the PC-AKI group compared to the controls, whereas the PC-AKI 
with glycyrrhizin group showed lower protein expression levels than the PC-AKI group (intracellular; P = 0.004; 
cytoplasmic; P = 0.008). Conversely, the expression of nuclear HMGB1 decreased in the PC-AKI group com-
pared to the controls (nucleus; P < 0.001), whereas it significantly increased in the PC-AKI with glycyrrhizin 
group compared to the PC-AKI group (nucleus; P = 0.003). (Fig. 2A). Full-length blots are displayed in Sup-
plementary Figure 1. Serum HMGB1 concentrations were also higher in the PC-AKI group compared to the 
controls (P < 0.001). Serum HMGB1 concentrations were lower in the PC-AKI with glycyrrhizin group than the 
PC-AKI group (P < 0.001) and similar to that of the controls (Fig. 2B).
Figure 1.  Glycyrrhizin attenuates oxidative stress. Oxidative stress was evaluated with MDA levels in the serum 
(A) and  H2DCFDA staining in kidney tissue (B). Oxidative stress was significantly higher in the PC-AKI group 
compared to the controls, whereas it was mitigated in the PC-AKI with glycyrrhizin group. Magnification = 10X, 
Scale bar = 100 μm. Results were expressed as means ± SEMs. N = 8 for each group. Statistical significance: 
***P < 0.001 Con vs PC-AKI, ###P < 0.001 PC-AKI vs GL + PC-AKI. Abbreviation: PC-AKI, post-contrast acute 
kidney injury; GL, glycyrrhizin; MDA, malondialdehyde.
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Effect of glycyrrhizin on the mRNA expression of pro‑inflammatory cytokines in PC‑AKI. To 
examine the protective effect of glycyrrhizin on the inflammatory process, we assessed mRNA expression lev-
els using RT-PCR. The mRNA expressions of IL-1α, IL-1β, IL-6 and TNF-α were all significantly upregulated 
in the PC-AKI group compared to the controls (IL-1α; P = 0.09, IL-1β; P < 0.001, IL-6; P = 0.020 and TNF-α; 
P = 0.004). As expected, the expression of all pro-inflammatory cytokines decreased in the PC-AKI with glycyr-
rhizin group compared to the PC-AKI group. (IL-1α; P = 0.040, IL-1β; P = 0.040, IL-6; P = 0.040 and TNF-α; 
P = 0.003) (Fig. 3A–D).
Glycyrrhizin‑mitigated kidney injury in PC‑AKI. Next, we evaluated the mRNA expression levels of 
kidney injury markers using RT-PCR. The expressions of KIM-1, NGAL and IL-18 were higher in the PC-AKI 
group compared to the controls (P < 0.001). Pretreatment with glycyrrhizin seemed to reduce the expression 
levels of these genes compared to the PC-AKI group (KIM-1 and NGAL; P = 0.020, IL-18; P = 0.001) (Fig. 4A–C). 
In addition, we further investigated whether NSAID and L-NAME could affect the kidney and found that there 
were no significant differences in renal function (Scr and BUN) and kidney injury markers between the controls 
and the NSAID + L-NAME group (P > 0.999) (Supplementary Figure 2). We also confirmed urinary KIM-1 and 
serum IL-18 levels using ELISA. We found that the concentrations of KIM-1 and IL-18 significantly higher in 
the PC-AKI group compared to the controls (P < 0.001), whereas they were lower in the PC-AKI with glycyr-
Figure 2.  Effect of glycyrrhizin on HMGB1 protein expression. (A) Representative western blot bands of 
HMGB1 with intracellular total protein, nucleus and cytoplasmic protein isolation. Expression levels were 
normalized to β-actin. The expressions of intracellular and cytoplasmic HMGB1 were significantly increased in 
the PC-AKI group compared to the controls, and were significantly reduced in the PC-AKI with glycyrrhizin 
group. On the other hand, the expression of nucleus HMGB1 in PC-AKI group significantly reduced compared 
to the control, but was significantly increased PC-AKI with glycyrrhizin group. The β-actin was used as a 
cytoplasmic and intracellular marker and LaminB1 as a nuclear marker. (B) The serum HMGB1 measured 
by ELISA was significantly higher in the PC-AKI group compared to the controls, but was significantly lower 
in the PC-AKI with glycyrrhizin group. Images of blots were cropped. Full-length blots are presented in 
Supplementary Figure 1. Results were expressed as means ± SEMs. N = 8 for each group. Statistical significance: 
*P < 0.05, ***P < 0.001 Con vs PC-AKI and Con vs PC-AKI + GL, ##P < 0.01 and ###P < 0.001 PC-AKI vs 
GL + PC-AKI. Abbreviation: PC-AKI, post-contrast acute kidney injury; GL, glycyrrhizin.
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rhizin group compared to the PC-AKI group (KIM-1; P < 0.001 and IL-18; P = 0.008). (Supplementary Figure 3). 
In addition, serum LDH was assessed as an early renal damage biomarker. LDH concentrations were higher in 
the PC-AKI group compared to the controls (P < 0.05). On the other hand, LDH levels were lower in PC-AKI 
pretreated with glycyrrhizin (P = 0.040) (Fig. 4D).
We evaluated the degree of apoptosis by the caspase-3 mRNA and cleaved caspase-3 protein levels. Apoptosis 
was significantly increased in the PC-AKI group compared to the controls, but with significant mitigation in 
the PC-AKI with glycyrrhizin group compared to the PC-AKI group (caspase3; P = 0.002, cleaved caspase-3; 
P < 0.001) (Fig. 5A,B). Immunohistochemistry results for cleaved caspase-3, TUNEL staining and TEM images 
also indicated that apoptosis increased in the PC-AKI group compared to the controls and that it decreased after 
pretreatment with glycyrrhizin (Fig. 5C–E). Full-length blots are displayed in Supplementary Figure 1.
Effect of glycyrrhizin on renal function in PC‑AKI. We also confirmed the protective effect of gly-
cyrrhizin on renal function in PC-AKI. As shown in Fig. 6, SCr and BUN were higher in the PC-AKI group 
compared to the controls (P < 0.001). However, both SCr and BUN were lower in the PC-AKI with glycyrrhizin 
group than in the PC-AKI group (P < 0.001) (Fig. 6A,B).
Effect of glycyrrhizin on renal histopathology in PC‑AKI. Histological appearance was compared 
between the controls, PC-AKI and PC-AKI with glycyrrhizin in Fig. 7. In H&E staining, prominent tubular 
dilatation was noted in the PC-AKI group. In the PC-AKI with glycyrrhizin group, tubular dilatation was less 
prominent (Fig. 7A). On TEM, vacuolization was noted in the cytoplasm of tubular cells in PC-AKI and the PC-
AKI with glycyrrhizin group had a lower degree of vacuolization than the PC-AKI group (Fig. 7B).
HMGB1 knock‑down inhibiting the expression of HMGB1, pro‑inflammatory cytokines, and 
kidney injury markers after contrast media exposure. To verify the effect of endogenous HMGB1 
on NRK52E cells, the HMGB1 gene was knocked down using siRNA methods (Fig. 8A). The mRNA expres-
sions of HMGB1, all of the pro-inflammatory cytokines and kidney injury markers did not increase after expo-
sure to contrast media with/without glycyrrhizin when HMGB1 was knocked down compared to the controls 
(Figs. 8B–F and 9).
Figure 3.  Effect of glycyrrhizin on the mRNA expression of pro-inflammatory cytokines. (A-D) Relative 
expressions of IL-1α, IL-1β, IL-6 and TNF-α mRNA were analyzed using RT-PCR. All pro-inflammatory 
cytokines were higher in PC-AKI compared to the controls with/without statistical significance, whereas they 
were lower in the glycyrrhizin pretreatment group. Results were expressed as means ± SEMs. N = 8 for each 
group. Statistical significance: *P < 0.05, **P < 0.01 and ***P < 0.001 Con vs PC-AKI. #P < 0.05 and ##P < 0.01 
PC-AKI vs GL + PC-AKI. Abbreviation: PC-AKI, post-contrast acute kidney injury; GL, glycyrrhizin.
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Discussion
Our results demonstrated that oxidative stress and inflammatory cytokines including IL-1, IL-6 and TNF-α 
increased in the PC-AKI model. Kidney injury makers such as KIM-1, NGAL and IL-18 also increased after 
exposure to contrast media. Furthermore, cytoplasmic and serum HMGB1 increased along with total cellular 
HMGB1 in the PC-AKI model. In this model, we could see that glycyrrhizin effectively mitigated kidney injury 
after contrast media exposure. Renal function impairment and histologic change was also attenuated with glycyr-
rhizin pretreatment. These results suggest that HMGB1 plays an important role in the development of PC-AKI 
and that glycyrrhizin has a protective effect against PC-AKI.
HMGB1 contributes to the development of many renal diseases including ischemic reperfusion injury, renal 
fibrosis due to chronic kidney disease, diabetic nephropathy, and granulomatous  nephritis7,8,13. HMGB1 is also 
thought to be involved in the development of PC-AKI as increased levels of HMGB1 were found in the super-
natants of previous cell experiments after cells were exposed to contrast  media14. These results were comparable 
to our animal study which also found increased serum HMGB1 in the PC-AKI group. We also showed that total 
cellular HMGB1 as well as cytoplasmic and serum HMGB1 increases after the administration of contrast media, 
suggesting that HMGB1 might be actively translocated from the nucleus to the cytoplasm after contrast media 
exposure. In previous studies, the extracellular release of HMGB1 upregulated the release of pro-inflammatory 
 cytokines6,15,16. This was also noted here as pro-inflammatory cytokines including IL-1α, IL-1β, IL-6 and TNF-α 
significantly increased in the kidney tissue of the PC-AKI group compared to the controls.
Glycyrrhizin directly binds to HMGB1 by interacting with two concave shallow surfaces and inhibits 
the chemotactic function of  HMGB111. Through this, glycyrrhizin can ameliorate sepsis-induced AKI, renal 
ischemic-reperfusion injury, gentamicin-induced AKI and diabetic kidney  disease10,12,17–19. In our results, pro-
inflammatory cytokines decreased in the PC-AKI with glycyrrhizin group and SCr and BUN were significantly 
lower in the PC-AKI with glycyrrhizin group compared to the PC-AKI group. These results suggest that the 
deterioration of renal function after contrast media exposure could be mitigated with glycyrrhizin by blocking 
HMGB1 and subsequently, the pro-inflammatory cytokines.
PC-AKI is thought to be caused by both renal hemodynamic changes and direct renal parenchymal  damage20. 
The latter might be due to the direct toxicity of iodine contained in the contrast media to the tubular epithelial 
cells and endothelial cells or due to enhanced production of ROS by the contrast media, resulting in increased 
oxidative  stress2,20. Hence, the cytotoxicity of contrast media might be ameliorated by reducing oxidative stress. 
Glycyrrhizin is one well-known  antioxidant21. According to previous studies, oxidative stress can be reduced by 
Figure 4.  Effect of glycyrrhizin on the mRNA expression of kidney injury markers and serum lactate 
dehydrogenase (LDH). (A-C) Relative expressions of KIM-1, NGAL and IL-18 mRNA were measured using 
RT-PCR. The mRNA expression of kidney injury markers was significantly higher in the PC-AKI group 
compared to the controls, whereas it was significantly lower in the PC-AKI with glycyrrhizin group. (D) 
Compared to the control group, serum LDH levels significantly increased in PC-AKI, whereas they decreased 
with glycyrrhizin pretreatment. Results were expressed as means ± SEMs. N = 8 for each group. Statistical 
significance: *P < 0.05 and ***P < 0.001 Con vs PC-AKI and Con vs PC-AKI + GL, #P < 0.05 and ##P < 0.01 
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glycyrrhizin in sepsis- or gentamicin-induced AKI, preventing further renal  injury17,18. We also demonstrated 
that glycyrrhizin could reduce oxidative stress after the administration of contrast media and this might partly 
contribute to the protection of renal function in PC-AKI.
SCr has two innate drawbacks that limit its role in the early diagnosis of AKI. Changes in SCr become appar-
ent slower than benign acute kidney injury due to its large volume of distribution and SCR has a narrow time 
window for the detection of kidney injury due to its sharp decrease after GFR recovery. Thus, other biomarkers 
such as NGAL, KIM-1, IL-18 and LDH have been suggested instead of  SCr22,23. In a previous study, these early 
biomarkers of AKI also increased in PC-AKI23–25. In our study, not only SCr and BUN, but also early biomarkers 
including the mRNA expression levels of KIM-1, NGAL, IL-18 and serum levels of LDH increased significantly 
in the PC-AKI group, while significantly decreasing after glycyrrhizin pretreatment. Furthermore, apoptosis was 
also attenuated by pretreatment with glycyrrhizin. These results suggested that the administration of glycyrrhizin 
could mitigate kidney injury caused by contrast media.
The vacuolization of tubular epithelial cells is one of the histopathological change of PC-AKI. It is known as 
an early sign of PC-AKI, although the degree of vacuolization does not correlate with the deterioration of renal 
 function20,26. In our study, we observed that prominent vacuolization of tubular cells that was noted in the PC-
AKI model was mitigated after glycyrrhizin pretreatment.
Figure 5.  Glycyrrhizin-mitigated apoptosis by PC-AKI. Relative expressions of caspase-3 mRNA (A) and 
protein levels of cleaved caspase-3 (B) were significantly increased in the PC-AKI group compared to the 
controls, whereas they were significantly lower in the PC-AKI with glycyrrhizin group than the PC-AKI group. 
(C-D) The immunohistochemistry of cleaved caspase-3 and TUNEL indicated apoptotic cells (arrowheads) 
in the PC-AKI group. Magnification = 20X, Scale bar = 100 μm. (E) TEM images shows that the area of 
apoptosis (arrows) in the kidney tissue of PC-AKI is wider than that of the PC-AKI with glycyrrhizin group. 
Magnification = 3 K, Scale bar = 5000 nm. Images of blots were cropped. Full-length blots are presented 
in Supplementary Figure 1. Statistical significance: **P < 0.01 and ***P < 0.001 Con vs PC-AKI, ##P < 0.01 
and ###P < 0.001 PC-AKI vs PC-AKI + GL. Abbreviation: PC-AKI, post-contrast acute kidney injury; GL, 
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Although experimental and clinical studies have found biological and functional evidence of contrast media 
playing a role in the development of PC-AKI, concerns have been raised that contrast media is not an actual 
predisposing factor for PC-AKI. Previous studies have stated that there is no association between contrast media 
and renal function including the incidence of AKI, need for renal replacement therapy, and mortality in sepsis 
 patients27 or intensive care unit  patients28,29 and this has been seen in even a meta-analysis30. These conflicting 
results might be due to both the difficulties in defining or composing control groups with a retrospective study 
design and the near impossibility of performing a prospective randomized trial. However, the American Col-
lege of Radiology clearly states in its manual on contrast media that PC-AKI is a rare, but real disease  entity31. 
Hence, in addition to research on methods to prevent or attenuate PC-AKI, we also need to explore associations 
between contrast media and PC-AKI in the future.
There were a couple of limitations to this study. First, the expression of RAGE, TLR2 and CXCR4 which are 
known as receptors of HMGB1 on the cell surface, and NF-kB which is a downstream factor of HMGB1 were 
not evaluated in this  study14. Second, the physiology and anatomy of rats and humans differ and these differences 
Figure 6.  Effect of glycyrrhizin on renal function. (A-B) Compared to the controls, SCr and BUN significantly 
increased in the PC-AKI group, whereas they decreased in the PC-AKI with glycyrrhizin group compared 
to the PC-AKI group. Results were expressed as means ± SEMs. N = 8 for each group. Statistical significance: 
***P < 0.001, Con vs PC-AKI and Con vs GL + PC-AKI, ###P < 0.001, PC-AKI vs GL + PC-AKI. Abbreviation: 
PC-AKI, post-contrast acute kidney injury; GL, glycyrrhizin; Scr, serum creatinine; BUN, blood urea nitrogen.
Figure 7.  Effect of glycyrrhizin on kidney histology. (A) Histological appearance of kidney tissue after H&E 
staining. Compared to the controls, renal tubular dilatation was prominent in PC-AKI, whereas it was mitigated 
in the PC-KAI with glycyrrhizin group. Magnification = 20X, Scale bar = 100 μm. (B) Transmission electron 
microscopy (TEM) images show multiple large vacuoles in the cytoplasm of the PC-AKI group, but this 
phenomenon was alleviated in the PC-AKI with glycyrrhizin group. Magnification = 5 K, Scale bar = 5000 nm 
(B-C). Statistical significance: ***P < 0.001 Con vs PC-AKI, ###P < 0.001 PC-AKI vs PC-AKI + GL. Abbreviation: 
PC-AKI, post-contrast acute kidney injury; GL, glycyrrhizin; TEM, transmission electron microscopy.
8
Vol:.(1234567890)
Scientific Reports |        (2021) 11:15625  | https://doi.org/10.1038/s41598-021-94928-5
www.nature.com/scientificreports/
Figure 8.  Knocking down HMGB1 inhibits the mRNA expression of HMGB1 and pro-inflammatory cytokines 
after contrast media exposure. (A) Knocking down HMGB1 inhibits the mRNA expression of HMGB1 
compared to the controls and negative control. (B-F) The mRNA expression of HMGB1 and all of the pro-
inflammatory cytokines did not significantly increase after cells were exposed to contrast media or contrast 
media + glycyrrhizin after knocking down HMGB1. (C-F). Results were expressed as means ± SEMs of three 
independent experiments, which were each performed in duplicate. Statistical significance: *P < 0.05, **P < 0.01 
and ***P < 0.001 Con vs CM and Con vs CM + GL, Con vs siHMGB1 ##P < 0.01 and ###P < 0.001, CM vs CM + GL, 
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will need to be addressed before our findings can be applied in clinical practice. And lastly, only male rats were 
used in this experiment.
In conclusion, this study showed that HMGB1 plays an important role in the development of PC-AKI and 
that glycyrrhizin has a protective effect on renal function by inhibiting HMGB1 and reducing oxidative stress.
Material and methods
Animal preparation. Institutional Animal Care and Use Committee of Yonsei University Health System 
approved this experiment (ID number of 2019–0137) and all methods were carried out in accordance with rel-
evant guidelines and regulations. Additionally, the animal experiment procedures were performed according to 
the ARRIVE guidelines. Twenty-four Sprague–Dawley male rats were used in this study (body weight:200-220 g). 
Rats were housed in an Animal Laboratory and maintained in a sterile 12 h light and 12 h dark experimental 
animal environment with 50 ± 100% humidity and 22 ± 2  °C temperature before the  experiment32. Rats were 
classified into 3 groups: the control group (n = 8), PC-AKI group (n = 8) and PC-AKI with glycyrrhizin group 
(n = 8). There was no significant difference in body weight among the three groups (P = 0.190). At first, water was 
restricted for all groups for 16-24 h. In the PC-AKI model, 10 mg/kg of indomethacin (Sigma-Aldrich, St. Louis, 
MO) and 15 mg/kg of L-NAME (Cayman Chemical, Ann Arbor, MI) were administrated via an intraperitoneal 
injection (IP). After 20 min, 10 ml/kg of iodinated contrast media (Pamiray 370, Dongkook Lifescience, Seoul, 
South Korea) was administrated by intravenous injection (IV) through the tail  vein33. In the PC-AKI with gly-
cyrrhizin group, 30 mg/kg of glycyrrhizin (Selleckchem, Huston, TX) dissolved in saline was intraperitoneally 
administered 2 h before PC-AKI model construction. In all the other groups, the same volume of saline was 
administered but without glycyrrhizin. After 24 h, rats were anesthetized with 1.5% isoflurane in a mixture of 
nitrous oxide (0.7L/min) and oxygen (0.3L/min) and blood pressure was measured with the following methods: 
endotracheal intubation was done using a 16G angiocatheter (Becton, Dickinson and Company, Franklin lakes, 
NJ) and anesthesia was maintained with 1.5% isoflurane in a mixture of 80% nitrous oxide and 20% oxygen. 
The left inguinal area was shaved and rats were locally anesthetized using a local infiltrative anesthetic (0.2% 
Bupivacaine). Then, the left femoral artery was exposed and ligated distally with 4–0 black silk. After clipping the 
proximal part of the left femoral artery using a microclip, a small incision was made between the microclip and 
ligation with a microscissor. During microclip removal, an indwelling polyethylene-50 tube (Scientific Com-
modities Inc., Lake Havasu City, AZ) was inserted and pushed forward to the inguinal ligament level through the 
femoral artery. To measure arterial blood pressure, a left femoral arterial catheter was connected to the Lifewin-
dow LW9x multi-parameter physiologic monitoring device (Digicare Biomedical Technology, Inc., Boston 
Beach, FL) through a 25 IU/ml heparin-filled invasive blood pressure transducer (Utah medical products, Inc., 
Midvale, Utha). The invasive blood pressure transducer was placed at heart level. After a stable and clear arterial 
waveform was obtained from the left femoral artery, the catheter was fixed with 4–0 black silk. Body temperature 
and end-tidal carbon dioxide were monitored using a rectal thermoprobe and capnography on a Lifewindow 
LW9x multi-parameter physiologic monitor to ensure the physiologic condition of the rat was constant during 
the entire procedure. Systolic pressure, diastolic pressure and calculated mean arterial pressure (MAP) were col-
lected 3 min after finishing the procedure. There was no statistical difference among the 3 groups (P = 0.170) for 
blood pressure (Supplementary Figure 4). After blood pressure was measured, rats were euthanized using a  CO2 
incubator and the kidney tissue was harvested.
Figure 9.  Knocking down HMGB1 inhibits the mRNA expression of kidney injury markers after contrast 
media exposure. (A-C) The mRNA expressions of KIM-1, NGAL and IL-18 mRNA were measured using 
RT-PCR. Similar to pro-inflammatory cytokines, the mRNA expression of kidney injury markers did not 
significantly increase after cells were exposed to contrast media or contrast media + glycyrrhizin after knocking 
down HMGB1. Results were expressed as means ± SEMs for the three independent experiments, which were 
each performed in duplicate. Statistical significance: **P < 0.01 Con vs siHMGB1 + CM + GL. #P < 0.05, ##P < 0.01 
and ###P < 0.001, CM vs CM + GL, CM vs siHMGB1 + CM, CM vs siHMGB1 + CM + GL. Abbreviation: NC, 
negative control; CM, contrast media; GL, glycyrrhizin.
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Kidney function evaluation. After euthanasia, blood was collected without anticoagulants from a cardiac 
puncture of rats through the right atrium with a 26-gauge syringe needle and centrifuged at 3000 rpm for 20 min 
to obtain the serum. The serum levels of blood urea nitrogen (BUN), serum creatinine (SCr) and lactate dehy-
drogenase (LDH) were measured using a Cobas C502 autoanalyzer (Roche, Mannheim, Germany).
Cell culture and contrast media exposure. The NRK52E cell line (immortalized normal rat renal 
proximal tubular cells) were cultured in DMEM with 5% FBS and 100U/ml penicillin–streptomycin at 37 °C in 
a humidified incubator with 5%  CO2 for growth. When the cell confluence was 85%, the cells were exposed to 
200 mg I/ml contrast media (Pamiray 370, Dongkook Lifescience, Seoul, South Korea) for 2 h. The glycyrrhizin 
pretreatment group was pretreated with 150 uM of glycyrrhizin (Selleckchem, Huston, TX) 90 min before con-
trast media exposure.
RNA interference. We used siRNA that targeted HMGB1 to inhibit HMGB1 expression. The sense 
sequence was 5’-CUG CUU AGU UUA GGG AAC A-3’, and the antisense sequence was 5’-UGU UCC CUA 
AAC UAA GCA G-3’. HMGB1 siRNA was transiently transfected into NRK52E cells with Lipofectamin 2000 
(Invitrogen, Carlsbad, CA).
Quantitative real‑time polymerase chain reaction. Total RNA was extracted from the kidney tissue 
using a commercial kit according to the manufacturer’s instructions (Hybrid-R kit 305–101, GeneAll Biotech-
nology, Seoul, South Korea)34. 1 μg of the total RNA was reverse transcribed with amfiRivert cDNA synthesis 
(GenDEPOT, Huston, TX) according to the manufacturer’s instructions. mRNA expression levels of HMGB1, 
KIM-1, NGAL, IL-1α, IL-1β, IL-6, IL-18 and caspase-3 were assessed using the SYBR-Green reagent (GenDE-
POT, Huston, TX) with the ABI7500 real-time polymerase chain reaction (RT-PCR) system (Applied biosystem, 
Foster city, CA) and normalized to β-actin. Gene expression was quantified using β-actin as the internal loading 
control. All RT-PCR reactions were duplicated and threshold (Ct) values were analyzed by the  2(−ΔΔCt) method. 
The primer sequences for real-time PCR are given in Table 1.
Western blotting. The harvested kidney tissue was homogenized and lysed in a pro-prep extraction 
solution (iNtRON Biotechnologist, Seong-nam, Korea) followed by protein quantitation with the Bradford 
 method34. In addition, nucleus and cytoplasmic proteins were extracted using NE-PER Nuclear and Cytoplas-
mic Extraction reagents (Thermo Scientific, Rockford, IL, USA). Lysates were fractioned on 10–15% sodium 
dodecyl sulfate (SDS)-polyacrylamide gels and transferred to polyvinylidene difluoride membranes. The mem-
branes were incubated overnight at 4 °C with primary antibodies against HMGB1 (1:1000, #ab18256, Abcam, 
Cambridge, MA), cleaved caspase-3 (1:1000, #9664, Cell signaling, MA, USA) β-actin (1:10000, #LF-PA0207, 
AbFrontier, Seoul, South Korea) and LaminB1 (1:1000, #12586, Cell signaling, MA, USA). After the membranes 
were washed three times in 1xTBS-T for 15 min each, they were incubated with HRP-conjugated secondary 
antibodies (goat anti-rabbit IgG-HRP, 1:10000 #SA002-500, GenDepot, Houston, TX) for 1 h at room tempera-
ture. Then the membranes were washed three times in 1xTBS-T for 15 min again. The blotted membranes were 
visualized by ECL reagents and exposed to X-ray film. The results were normalized to the β-actin and LaminB1 
loading control and band density was measured using Image J software (National Institutes of Health, Bethesda, 
MD, https:// imagej. nih. gov/ ij)34.
Enzyme‑linked immunosorbent assay (ELISA). To measure rat serum HMGB1, IL-18 and urinary 
KIM-1, we used the Rat HMGB1 ELISA kit (E-EL-R0505, Elabscience, Houston, Tx), Rat IL-18 ELISA kit 
(ab213909) and Rat KIM-1 ELISA kit (ab223858, Abcam, Cambridge, MA) according to the manufacturer’s 
instructions. Absorbance levels of the concentrations were measured at 450  nm using a microplate reader 
(Molecular Devices, Sunnyvale, CA).
Table 1.  Primer sequences.
Target gene Forward sequence (5′–3′) Reverse sequence (5′–3′)
β-actin TGG CAC CCA GCA CAA TGA A CTA AGT CAT AGT CCG CCT AGA AGC A
KIM-1 AAC GCA GCG ATT GTG CAT CC GTA CAC TCA CCA TGG TAA CC
NGAL GAT GAA CTG AAG GAG CGA TTC TCG GTG GGA ACA GAG AAA AC
IL-18 AAA CCC GCC TGT GTT CGA ATC AGT CTG GTC TGG GAT TCGT 
HMGB1 ATG GGC AAA GGA GAT CCT A ATT CTC ATC ATC TCT TCT 
IL-1α CTC TAG AGC ACC ATG CTA CAGAC TGG AAT CCA GGG GAA ACA CTG 
IL-1β ATG GCA ACT GTT CCT GAA CTC AAC T CAG GAC AGG TAT AGA TTC TTT CCT TT
IL-6 AGG ATA CCA CTC CCA ACA GACCT CAA GTG CAT CAT CGT TGT TCA TAC 
TNF-α AGC CCT GGT ATG AGC CCA TGTA CCG GAC TCC GTG ATG TCT AAG 
Caspase-3 ACT GGA AAG CCG AAA CTC TTC ATC A GGA AGT CGG CCT CCA CTG GTATC 
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Determination of MDA concentration. Membrane lipid peroxidation was assessed by measuring 
malondialdehyde (MDA), a product of membrane lipid peroxidation, using 2-thiobarbituric acid reactive sub-
stances. The MDA levels were calculated as MDA equivalents using a commercial kit Cat#10009055 (Cayman 
Chemical, Ann Arbor, MI) according to the manufacturer’s  instructions34.
Histology, immunofluorescence and  H2DCFDA staining. Kidney tissue was fixed with 10% buffered 
formalin embedded in paraffin, and cut into 4 μm sections. The paraffin-embedded tissues were deparaffinized 
by xylene and rehydrated in increasing concentrations of ethanol (70%, 90%, 95%, 100%). Then, H&E staining 
was performed using the Leica Autostainer. Renal tubular damage was assessed with the following score system: 
score of 0 (no injury); score of 1 (< 10%, minimal); score of 2 (10–25%, mild); score of 3 (25–50%, moderate); 
score of 4 (50–74%, severe), and score of 5 (> 75%, very severe)35. For  H2DCFDA staining, the sectioned slide 
was deparaffinized and incubated with 10 μM  H2DCFDA for 15 min in a 37 °C incubator. The stained slides were 
observed with a confocal microscope (LSM700, Carl Zeiss GmbH, Jena, Germany).
TUNEL staining. To determine the degree of apoptosis in the kidney, we performed the terminal deoxy-
nucleotidyl transferase (TdT)-mediated dUTP nick-end-labeling (TUNEL) assay using the TACS 2 TdT-DAB 
in situ apoptosis detection kit Cat#4810–30-K (Trevigen inc., Gaithersburg, MD, USA) according to the manu-
facturer’s instructions.
Transmission electron microscopy (TEM). Kidney tissue was fixed overnight in 0.1 M phosphate buffer 
(PH7.4) containing 2% glutaraldehyde, 2% paraformaldehyde and 0.5%  CaCl2. The samples were washed twice 
with 0.1 M phosphate buffer for 30 min and were then fixed for 2 h with 1%  OsO4 dissolved in 0.1 M phosphate 
buffer, followed by dehydration through a series of increasing ethanol concentrations (50–100% with increments 
of 10%) with 10 min being allocated for each concentration. Specimens were embedded by poly/Bed812 kit (Pol-
yscience, Inc., Warrington, PA) and polymerized at 65 °C in an electron micro-oven (TD-700, DOSAKA, Kyoto, 
Japan) for 24  h32. Blocks were cut using an ultramicrotome (LEICA EM UC-7, Leica Microsystem, Vienna, 
Austria) and observed with TEM (JEM-1011, JEOL, Tokyo, Japan). To assess the effect the contrast media and 
glycyrrhizin had on cells, we evaluated cellular vacuolization by performing TEM with the same image magni-
fication (5 K) and the number of vacuoles within the tubular cell in the field of view of each TEM image were 
counted by an experienced researcher who was blinded to the study results.
Statistical analysis. All results were presented as means ± standard errors of the mean (SEMs). Statistical 
analyses were performed using Prism 8.3.0 (Graphpad, San Diego, CA). One-way analysis of variance (ANOVA) 
and post-hoc comparisons (Bonferroni test) were performed to compare the 3 groups. P value of less than 0.05 
was considered to indicate a statistically significant difference. All P-values were two-sided.
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